Biogen Inc. (BIIB)
Biogen Inc. (BIIB) Stock Price: $199.10+6.48 (+3.36%)
The total return cagr for Biogen Inc. (BIIB) stock is 48.46% over the past 12 months. The 3 year average growth rate is -13.61% and the 5 year cagr is -13.32%. Total return includes dividends reinvested.
The closing share price for Biogen Inc. (BIIB) stock was $199.10 for Tuesday, June 9, 2026, up +3.36% from the previous day.
BIIB Price Chart
End-of-day pricesAdvanced chart →
BIIB$199.10▲ 57.32%as of Jun 9, 2026
BIIB Key Metrics
See All MetricsBIIB Earnings Preview
Next Earnings Date
Jul 30, 2026
51 days away
EPS Estimate
1.94
Revenue Est.
$2.43B
Last Quarter Results
EPS
$3.57
vs Estimate
$2.89
Beat
Revenue
$2.48B
vs Estimate
$2.29B
Beat
BIIB Analyst Ratings
Consensus Rating
Buy
Based on 29 analysts
Strong Buy
2
Buy
18
Hold
15
Sell
1
Strong Sell
0
Average Price Target
$219.44
+10.2% upside
Low
$150.00
Current
$199.10
High
$300.00
BIIB Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $3.83 | N/A | 7 |
| Q2 2027 | N/A | $4.45 | N/A | 7 |
| Q3 2027 | N/A | $4.09 | N/A | 10 |
| Q4 2027 | N/A | $4.43 | N/A | 7 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $16.36 | N/A | 15 |
| FY 2028 | N/A | $18.28 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $2.52B | N/A | 7 |
| Q2 2027 | N/A | $2.60B | N/A | 7 |
| Q3 2027 | N/A | $2.63B | N/A | 10 |
| Q4 2027 | N/A | $2.66B | N/A | 7 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $10.09B | N/A | 15 |
| FY 2028 | N/A | $10.32B | N/A | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
BIIB Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1BIIB | $29.39B | $199.10 | +3.36% | +48.46% | -13.32% | -2.27% |
BIIB Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt